Condition
Mesothelioma
Estimated Enrollment: 20
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label
Study ID Numbers: H-36952
Study First Received: October 19, 2015
Last Updated: December 6, 2016
Estimated Primary Completion Date: May 2018
Primary Outcome Measures:
Intratumoral ratio of CD8 T cells to regulatory T cells (CD8/Treg). [Ratio]|The percentage of inducible T-cell co-stimulator (ICOS) + CD4 T cells.|The tumor expression programmed death-ligand 1 (PD-L1). [Semi-quantitative assessment: 0, 1+, 2+, 3+, 4+]
Sponsors and Collaborators:
Baylor College of Medicine
Website Link: https://ClinicalTrials.gov/show/NCT02592551
